semaglutide weekly dose (Wegovy) for the Treatment of Obesity Semaglutide and Tirzepatide Dosage Charts:

TRIUMPH-1 ran as a master protocol: an 80-week, randomized, double-blind, placebo-controlled study in 2,339 adults with obesity or overweight and without diabetes

Patients across Utah often see better blood sugar control, lower blood pressure, reduced cholesterol, and a decreased risk of heart attack and stroke

population aged 12 and older (SAMSHA 2024)

If youve been reading this newsletter, you know Ive written about the fact that OA patients on GLP-1 drugs report pain improvement long before any meaningful weight loss occurs

By purchasing, you acknowledge you are a qualified researcher (21+)

That matters because, historically, a large portion of the fitness industry built itself around one primary promise: helping people lose weight